Use of the AGREE II instrument to evaluate critical care practice guidelines addressing pharmacotherapy.

{"article_title":"Use of the AGREE II instrument to evaluate critical care practice guidelines addressing pharmacotherapy.","author":"Linn DD, Beckett RD, Faust AC","journal_title":"Journal of evaluation in clinical practice","issn":"1365-2753","isbn":"","publication_date":"2022 Dec","volume":"28","issue":"6","first_page":"1061","page_count":"","accession_number":"35441442","doi":"10.1111\/jep.13687","publisher":"Wiley-Blackwell","doctype":"Journal Article","subjects":"Critical Care; Humans; Cross-Sectional Studies; Reproducibility of Results","interest_area":["Surgery"," Emergency Medicine"],"abstract":"Rationale, Aims and Objectives: Clinical practice guidelines (CPGs) have been evaluated for reporting transparency and methodological quality in a number of studies in various disciplines, but few studies have focused on critical care and none on pharmacotherapy-related guidelines specifically. The objective of this study was to evaluate the quality of critical care CPGs with a focus on pharmacotherapy using the Appraisal of Guidelines, Research and Evaluation (AGREE) II instrument. Method: A cross-sectional study of CPGs published from 2013 through August 2021 was conducted. Following establishment of interrater reliability, guidelines were independently evaluated by three reviewers to rate guidelines on criteria set forth by the AGREE II instrument. Domain scores and item scores were calculated using the AGREE II user manual, and results described with descriptive statistics. Results: Out of 192 guidelines identified, 73 met inclusion criteria and were screened using the AGREE II instrument. Most guidelines were authored by a professional organization or government agency. Domain quality scores were calculated for each domain as recommended by the AGREE II instrument. Domain 4 (clarity of presentation) had the highest AGREE II domain score with a median score of 87.0% (interquartile range: 79.6%-92.6%). Domain 5 (applicability) received the lowest domain score with a mean score of 41.8 \ufffd 21.1%. The majority of guidelines were recommended for use as published or with modifications, while only six guidelines (8.2%) were not recommended for use. Conclusions: The majority of critical care guidelines that include pharmacotherapy recommendations were recommended for use by study authors when the AGREE II instrument was applied. While guidelines generally scored highly in clarity of presentation, additional time and effort should focus on providing solutions to guideline implementation and inclusion of patient preferences. \ufffd 2022 John Wiley & Sons Ltd.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=35441442&authtype=shib&custid=ns346513","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"Linn DD, Beckett RD, Faust AC","Journal_Info":"Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9609066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2753 (Electronic) Linking ISSN: 13561294 NLM ISO Abbreviation: J Eval Clin Pract Subsets: MEDLINE","Publication_Type":"Journal Article","Published_Date":"2022-12-01","Source":"Journal of evaluation in clinical practice [J Eval Clin Pract] 2022 Dec; Vol. 28 (6), pp. 1061-1071. Date of Electronic Publication: 2022 Apr 19.","Languages":"English","Electronic_ISSN":"1365-2753","MeSH_Terms":"Critical Care*, Humans ; Cross-Sectional Studies ; Reproducibility of Results","Subjects":"Humans, Cross-Sectional Studies, Reproducibility of Results, Critical Care","Title_Abbreviations":"Journal of evaluation in clinical practice","Volume":"28"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"35441442","RelevancyScore":"904","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"904.446716308594"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=35441442&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=35441442&authtype=shib&custid=ns346513&group=main&profile=eds"}